IPO Stock Arcellx Breaks Out On $325 Million Cancer Deal With Gilead The post IPO Stock Arcellx Breaks Out On $325 Million Cancer Deal With Gilead appeared on BitcoinEthereumNews.com. Recent initial public offering Arcellx (ACLX) forged a $325 million multiple myeloma deal with Gilead Sciences (GILD) on Friday, and the IPO stock broke out. X The news comes in… Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Filed under: News - @ December 11, 2022 9:15 am